Stem cell therapy for recent spinal cord injury
Part of Brain & nervous system, Injuries & trauma clinical trials.
This phase 1 trial tests a new treatment made from stem cells (XS228) for people who had a spinal cord injury 14 to 60 days ago. Doctors want to see if it's safe and if it might help with recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You had a spinal cord injury in your neck or back (from C4 to L2) 2 weeks to 2 months ago.
- Your injury is rated as AIS grade A, B, or C (complete or incomplete, but not the mildest).
- You are healthy enough for a spinal tap (lumbar puncture) and can take medicines that suppress your immune system.
- You are not pregnant and are using effective birth control (non-hormonal) during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental treatment using special cells (called motor neuron cells) that are injected into the spinal fluid to see if they can help improve recovery after a recent spinal cord injury. It's for people who had a spinal cord injury 2 weeks to 2 months ago and have some loss of function.
This trial tests a new cell therapy called CE-1 for people with spinal cord injuries caused by trauma. The treatment is given as an injection into the fluid around the spinal cord, to see if it helps improve neurological function.
This study tests a combination of two experimental treatments for people with chronic spinal cord injury: an injection of stem cells around the spinal cord, and a non-invasive therapy that uses a mild electrical current on the skin to help the spinal cord work better. The goal is to see if this approach is safe and helps with recovery of movement and function.
This trial tests a cell transplant approach for people with a very severe spinal cord injury. It focuses first on safety and also looks for early signs the therapy may improve function.
This trial tests a new treatment made from stem cells (called XS228CN) injected into the spine. It is primarily a safety study, but doctors will also watch for any signs the treatment may slow ALS progression.
This Phase 1 study tests whether an off-the-shelf stem cell product made from donated umbilical cord tissue is safe for people with spinal cord injury. It mainly looks at side effects and safety, and may help pave the way for future effectiveness studies.
Hear when a new Clinical Trials trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.